Introduction
The amino acid glutamate is a major excitatory neurotransmitter in mammalian brain (Watkins and Evans, 1981) . MK-801, a potent anticonvulsant and neuroprotective agent, has been shown to noncompetitively bind to a subset of glutamate binding sites termed the N-methyl-n-aspartate (NMDA) receptor (Wong et al., 1986 (Wong et al., , 1988 . Activation of the 6Hs NMDA receptor opens a channel that permits Ca*+ and other cations to pass into the neuron. It is to this channel, when in the open state, that MK-801 is thought to bind. The psychotropic drug phencyclidine (PCP) has also been shown to bind to this NMDA-operated open channel (Honey et al., 1985 specificity; it has a KD of 6.3 nM for the NMDA receptor channel and little affinity for the sigma opiate receptor (Wong et al., 1988) .
The NMDA receptor complex may play a pivotal role in many brain diseases. Excessive stimulation of NMDA receptors has been implicated in neurodegenerative disorders such as Alzheimer's disease (Greenamyre et al., 1985; Deutsch and Morisha, 1988) psychotic processes (Olney, 1987) epilepsy (Meldrum, 1987) and ischemia-induced neuronal degeneration.
Initial studies in animal models of both global and focal ischemia have shown that MK-801 protects against glutamate-induced neuronal damage when given before or shortly after the ischemic insult (Kemp et al., 1987) .
The goal of this preliminary work was to explore strategies for synthesizing radiolabeled derivatives of MK-801 for in vivo mapping of the NMDAlinked cation channel.
Both radioiodinated and " C/'*F-tracers have been pursued in hopes of developing agents for evaluation by SPECT and PET, respectively. Synthetic routes to MK-801 and its analogs are described only in the patent literature; structure-activity relationship (SAR) studies have not been published.
This report describes the synthesis of two isomeric '25 I-labeled derivatives of (+) and a [i8F]fluoromethyl derivative. Results of K, value determinations for these three derivatives suggest that two of the tracers merit in vivo evaluation as NMDA receptor channel markers. 
Experimental

Materials and methods
(-t)MK-801 [( $)-5-methyl-IO,1 I-dihydro-5H-di- benzo[a,d
In vitro binding assa)
The affinity of the compounds for the NMDAlinked receptor channel was determined using the procedure of Vignon et al., (1983, 1986) were then calculated using the equation:
; the concentration of [3H]TCP (IL]) utilized in the inhibition studies was 6 nM.
Log P determination
The log P of MK-801 was determined according to the method of Frey et al. (1983) 
Preparation of (?)I-iodo-MK-801
To a solution of (k)MK-801 (315 mg, 1.40 mmol) in 85% H,SO, (17 mL) were added silver sulfate (222 mg, 0.21 mmol) and iodine (181 mg, 0.71 mmol). The resulting mixture was stirred at room temperature for 7 h. It was then cooled to 0°C and carefully neutralized with 10% NaOH. The neutral solution was extracted with CH,Cl, (3 x 10 mL) and the combined extracts were dried over MgSO, and concentrated in uacwo. GC/MS analysis of this crude material showed one major (tR = 
Synthesis of (_+,)I -['2sl]iodo-MK-801
Radioiodide labeling was achieved by an ammonium sulfate catalysed solid-phase exchange technique described previously (Mangner et al., 1982; Otto et al., 1986) . Exchanges were conducted in 3 mL septum sealed multi-dose vials vented with a disposable IOcm' plastic syringe which served as the distillate condenser. Charcoal and aqueous sodium thiosulfate traps were connected in series with the condenser to trap any volatile radioiodine that was released during the heating process. In a typical procedure, a solution containing 6.3 mg of (NH,),SO,, 25 pg of (&-)I-iodo-MK-801, and 6.5 mCi of Na12"I in 300 PL of ethanol/water (1 : 1) was heated to dryness in an oil bath at 180°C. Air (10 mL) was slowly injected over a I-min period, and the reaction mixture was maintained at 180-185°C for an additional 30min. After cooling to room temperature, the reaction mixture was extracted with acetone (5OOpL) and analyzed by radio-TLC (silica:Et,O:CH,CN:NH,OH, 70:30:5; R,=0.28; radiochemical yield 83%). Evaporation of the acetone left a residue which was extracted with CH,CI, (2 x 1 .O mL) and transferred to a silica Sep-Pak. The Sep-Pak was successively washed with 4 mL each of hexane, hexane/EtOAc (9: l), hexane/EtOAc (3: I), and hexane/EtOAc (1: 1) to remove less polar impurities. Subsequent elution with 4mL of EtOAc yielded 2.8 mCi of desired product; radiochemical purity was >99% by radio-TLC and isolated radiochemical yield was 47%. The specific activity was > 60 Ci/mmol.
The radioligand was stored in absolute ethanol (5.8mCi/mL) at -20°C in the dark until needed. Under these conditions, no radiolytic decomposition was observed up to 46 days after synthesis. Just prior to biological testing the solvent was evaporated and the compound was formulated in ethanol/5 mM sodium acetate buffer, pH 4.5, (15 : 85).
Synthesis of (_+)3-['251jiodo -MK-801
7.27 mCi of Na'251 were combined and heated to dryness at 230°C in an oil bath. Air was then slowly passed through the reaction vial for 1 min. The dry mixture was maintained at 230°C for an additional 30min, cooled to room temperature, dissolved in acetone (200 pL) and subjected to radio-TLC analysis (silica, CH,CN: Et,O:NH,OH, 3: 7:0.1). Following removal of the acetone by means of a gentle stream of argon, the dry reaction mixture was dissolved in CH,Cl, (3 x 0.5 mL) and transferred to a silica Sep-PakTM. Elution with hexanes (10 mL) followed by EtOAc (5 mL) removed the less polar impurities. Further elution with CH,CN (10 mL) afforded 1.67 mCi of ( f )3-['25 Iliodo-MK-801 in >95% radiochemical purity as determined by radio-TLC.
The radiochemical yield was 23%. HPLC was used for the preparative separation of ( +)3-['251]iodo-MK-801 from the precursor (f)3-bromo-MK-801.
The separation was made on an Ultremex IPTM column with guard column [0.46 x (25 + 5) cm, 5-pm particle, C-l 8; Phenomenex, Ranch0 Pales Verdes, Calif.] with a mobile phase consisting of a mixture of 50mM aqueous ammonium formate/CH,CN
(1 : 1) and a flow rate of 1.2 mL min'.
Under these conditions, the retention times for 3-bromo-MK-801 and 3-['251]iodo-MK-801 were 11.6 and 25.1 min, respectively. During elution of the radioactive peak, I-min fractions were collected and the heart fractions were pooled.
The effective specific activity and radiochemical purity were assayed by radio-HPLC. 
Synthesis of (_t)13-['8F]~uoromethyl-MK-801
To a solution of tetrabutylammonium ["Flfluoride in acetonitrile (lo&200 p L) was added a solution of 1 mg of either triflamide alcohol 8 or cyclic sulfamate 9 in 50 PL acetonitrile, and the solution heated (IOOC, closed vessel) for 5-15 min. The vessel was cooled slightly, then 200 p L of 6N HCl added and the aqueous mixture heated (lOO"C, closed vessel) for an additional 5-l 5 min. After brief cooling, the aqueous mixture was added dropwise to 10mL of saturated aqueous sodium bicarbonate.
This aqueous mixture was then passed through a C-18 Sep-Pak, which was further washed with 5 mL of water. The product was eluted with 4mL of chloroform and the organic solution dried over anhydrous sodium sulfate. In experiments performed simultaneously, radiochemical yields of "F-3 from triflamide alcohol 8 or cyclic sulfamate 9 were essentially identical, 72 and 74% EOB, respectively. 
Synthesis of azetidine 5
Trifluoromethane sulfonic anhydride (68 mg; 0.24 mmol) was added dropwise to a stirred solution of aminoalcohol 1 (50 mg; 0.20 mmol) in anhydrous CH,Cl, at -78°C under dry nitrogen. The mixture was stirred at -78C for an additional 45 min and then allowed to warm to room temperature over ca 15 min. The reaction was quenched by addition of saturated aqueous NaHCO, solution (1 mL); after stirring for IOmin, the aqueous layer was decanted and back-extracted with CH,Cl, (3 x 3 mL). The combined organic layer and extracts were dried over MgSO, and concentrated in vacua. The crude product was purified by flash chromatography using hexane:ethyl acetate (2: 1) and then 100% ethyl acetate to give 27 mg (58%) of the azetidine 5 as a colorless oil.
'H-NMR(CDC1, 
Cyclic carbamate 6
Di-t-butyl dicarbonate (92 mg; 0.42 mmol) in DMF (2mL) was added to a stirred solution of amino alcohol 1 (100 mg; 0.40 mmol) in DMF (6 mL) under argon. The reaction mixture was stirred for 2 h at room temperature and then concentrated under vacuum.
The residue was dissolved in CH,CI,, washed rapidly with 5% HCl, and dried over anhydrous MgSO,. The solvent was removed under vacuum to give 90 mg (64%) of carbamate as a clear oil. The above oil was dissolved in 3 mL of pyridine at 0°C and p-toluenesulfonyl chloride (50mg; 0.26mmol) was added. The reaction was stirred at 0°C for 2 h and then partitioned between water and CHCI,. The CHCI, layer was decanted and dried over anhydrous MgSO,. The solvent and residual pyridine were removed under vacuum to give 60 mg (83%) 
Results and Discussion
Chemistry
The direct iodination of (k )MK-801 by the Derbyshire method (Derbyshire and Waters, 1950) provided an unexpectedly simple monoiodinated product pattern. It was anticipated that under conditions of stoichiometric excess of (+)MK-801 at least four compounds, the 2-, 3-, 7-and the 8-monoiodo isomers might be formed. A major monoiodinated isomer was isolated from this reaction. The 'H and 13C NMR data, however, strongly support l-iodo-MK-801 as the structure of this compound. The aromatic region of the 'H NMR spectrum clearly shows a coupling pattern suggesting substitution of one of the four protons ortho to the seven-membered ring (i.e. C,H, C,-H, C,-H or C,-H). In addition, there is a small upfield shift in the signals of the two C,,-protons relative to parent MK-801, which can be attributed to a shielding effect by the iodine atom in the C, position. The last observation is reinforced by the significant downfield shift (ca 7.3 ppm), relative to MK-801, observed for C,, in the 13C NMR spectrum of the iodo compound.
This shift can be best attributed to the presence of the iodine atom in the adjacent C, position. Finally, direct comparison of the 'H and 13C NMR spectra of the monoiodo compound with those of 3-bromo-MK-801 also points to the I-iodo-MK-801 isomer as the structure of the product. Whether this remarkable preference for electrophilic attack at the l-position of MK-801 is unique to the Derbyshire reaction remains to be determined.
The identity of the two minor monoiodinated products has not been pursued.
The radiosynthesis of ( f)1-['251]iodo-MK-801 was readily achieved by the solid-state radioiodide exchange method previously developed in this laboratory (Mangner et al., 1983; Otto et al., 1986) . Rapid passage of the reaction mixture through a silica Sep-PakTM to eliminate unreacted radioiodide and other radioactive inorganics was the only purification necessary. A radiochemical yield of 83% was obtained ata specific activity of 60 Ci/mmol; higher specific activities (> 100 Ci/mmol) could be achieved but in lower yield.
The synthesis of (f)3-["'Iliodo-MK-801 was accomplished by interhalogen exchange with (f)3-bromo-MK-801. Subsequent use of HPLC was needed to separate most of the (i-)3-bromo-MK-801 precursor from the desired radioactive product. This HPLC enrichment gave ( +)3-['251]iodo-MK-801 with an effective specific activity of > 1350 Ci/mmol. The synthesis of unlabeled 3-iodo-MK-801
has not been reported and its synthesis is presently being pursued in our laboratory. Thus, the evidence for the identity of ( +)3-['251]iodo-MK-801 is indirect. The fact that only one radioactive organic product is formed and that its chromatographic behavior, both TLC and HPLC, is very similar to 3-bromo-MK-801, argues strongly for interhalogen exchange rather than proton-halogen exchange. Further support for interhalogen exchange rests on findings in our laboratory that ortho-chlorobenzylguanidine and PK-11195, an ortho -chlorophenyl derivative of isoquinohne, undergo exclusive interhalogen exchange with Na'*'I under the solid-state conditions employed here for (f)3-bromo-MK-801 (Gildersleeve et al., 1988) .
The most obvious strategy for labeling MK-801 with a positron-emitting radioisotope is to synthesize However, as shown in Table 2 , N-methyl-MK-801 has a 2-fold lower binding affinity than MK-801 in the [3H]TCP assay. Thus, alternatives to labeling MK-801 with carbon-11 have been pursued, especially those employing ["Flfluoride ion because of its longer half-life, ease of large-batch synthesis, and high specific activity. Our attention focused on the bridgehead methyl group as a possible locus for incorporating 18F. This approach was attractive since the synthesis of the methylenehydroxy derivative of MK-801, i.e. compound 1, has been described in the patent literature (Christy et al., 1979) . It was predicted that the triflate of this alcohol, 2, could serve as a precursor to 18F-3, the 1 3-[18 Flfluoromethyl derivative of MK-80 1. Alcohol 1 was synthesized in 7 steps from tram -10, 1 I-dibromodibenzosuberone.
Reaction of 1 with 1.2 equivalents of triflic anhydride failed to give the desired triflate 2; instead the azetidine derivative 5 was formed, seemingly through nitrogen attack on the triflate formed in situ. The azetidine was also observed in the reaction of 1 with DAST (Mislankar and Wieland, unpublished observation). Reaction of 1 with 2.5 equivalents of triflic anhydride gave the triflate sulfonamide 4. The imino group of 1 could be selectively functionalized as the t-BOC carbamate; however, subsequent attempts to form the triflate in the presence of organic bases resulted in intramolecular cyclization to the carbamate 6. Reaction of 1 with trityl chloride gave the 0-alkylated product 7; reaction of 7 with triflic anhydride followed by an aqueous acid workup yielded the triflamide 8. At this stage in our synthetic work, Merck scientists reported reaction is also remarkable in that it gives exceedingly high "F incorporation and a product of high radiochemical purity (> 99%). Isolated yields are as high as 68% (93% corrected for decay); virtually the only other fluorine-18 species is unreacted ['" Flfluoride ion which can be removed by a variety of methods, including liquid-liquid extraction or bonded-phase chromatography.
Chemical impurities are few, but are apparently different depending on the choice of starting material. Trace chemical impurities such as 1 are removed from the final product by HPLC purification. With further optimization studies, it will likely be possible to eliminate the tracer chemical impurities by a simple Sep-Pak procedure. When aqueous HCl is used in the radiochemical workup of the ['8F]fluoride reaction with the cyclic sulfamate 9, the chloromethyl analog 10 has been observed to form, seemingly through Cl-attack on the cyclic sulfamate 9. Use of the hydroxytriflamide 8 gives no chloromethyl contaminant on aqueous HCl workup. Compound 10 was synthesized separately by reaction of 1 with thionyl chloride. 
Binding and log P studies
Substitution of iodine in the l-position decreases the binding affinity IO-fold (Table 2) . Although unlabeled (+)3-iodo-MK-801
was not available for competitive binding studies, it is noteworthy that (+)3-bromo-MK-801, which is likely to mimic the 3-iodo isomer, has a loo-fold greater affinity than (+)MK-801 and a lOOO-fold greater affinity than (f)l-iodo-MK-801 for the TCP binding site. This high sensitivity to the halogen substitution pattern underscores the need to do further SAR studies. Results of binding studies with (k)N-methyl-MK-801 and ( + ) 13-fluoromethyl-MK-801, derivatives amenable to labeling with "C and 18F, respectively, show that N-methylation slightly lowers binding affinity, whereas fluoromethylation of the bridgehead methyl group has no observable effect on binding. The radiotracers synthesized in this study are racemic ligands; however the (+) enantiomers are expected to show enhanced binding (See Table 2 ).
It has become clear in recent years that a "window" of lipophihcity exists for optimum passage of a drug or tracer through the blood-brain barrier (Hansch et al., 1987) . This optimum log P is 2 _t 0.5. A log P value of 2.1 & 0.1 was obtained for free base
